ARCHIVES

VeriStrat Biomarker Test Predicts Treatment Outcomes In Phase III NSCLC Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

NSABP Operations Office Moves Across Town To Allegheny

December 13, 1996

Nobel Prize Recognizes Gene Targeting.

October 12, 2007

In Brief: Louise Strong Named President, AACR; Donald Coffey Is President-Elect

April 26, 1996

NCI-Approved Clinical Trials

August 31, 2001

Lymphoblastoid If Test Shows Toxicity Not From Impurity, Investigator Says

August 8, 1980

Brenner To Leave Breast Cancer Action

September 17, 2010